PATENT CLAIM ANALYSIS

Application Number: 15897628
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "045000"]

Abstract:
The invention provides compositions or pharmaceutical compositions for use in inducing acquired immune lymphocytes to produce type I interferons, inhibiting proliferation of the lymphocytes, and treating diseases or conditions associated with enhanced acquired immunity. Pharmaceutical compositions for use in treating diseases or conditions associated with enhanced acquired immunity, containing a STING ligand; compositions for use in inducing T cells to produce type I interferons, containing a STING ligand; and proliferation inhibitors of acquired immune lymphocytes containing a STING ligand are provided.

Claim (Index 9):
The method according to  claim 1 , wherein the method is for treating the disease or condition associated with enhanced acquired immunity in the subject in need thereof, and comprises administering a therapeutically effective amount of the STING ligand to the subject.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 88.0
- Lexical Diversity: 2.06977
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14280667', '15109945', '15241821', '15565609', '15665378']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6556310649870967
- 35 USC 102 Novelty (BERT): 0.5129504562450374
- Combined Prediction Score: 0.6413630041128907
- Mean Citation Score: 249.86114200000003
- Max Citation Score: 258.40125
- Similarity Product: 187.7791892959177

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test